• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
HBIO

HBIO

Harvard Bioscience, Inc.

NASDAQHealthcareMedical - Instruments & SuppliesUS

USD6.50

+0.04 (+0.62%)

Rating:C-

Company Profile

CEO

John Duke

IPO Date

2001-03-19

Sector

Healthcare

Industry

Medical - Instruments & Supplies

Exchange

NASDAQ

Country

US

Market Metrics

Open

$6.51

Prev. Close

$6.46

Day Low

$5.87

Day High

$6.60

52W Low

$3.70

52W High

$9.40

Market Cap

$0.03B

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

34.9%

Avg Negative

3.3%

Avg Neutral

62.0%

News Feed

Are You Looking for a Top Momentum Pick? Why Harvard Bioscience (HBIO) is a Great Choice

Zacks Investment Research·7/2/2021·↑ positive

Harvard Bioscience (HBIO) Is a Great Choice for "Trend" Investors, Here's Why

Zacks Investment Research·7/2/2021·↑ positive

4 Breakout Stocks You Must Add Right Away to Your Portfolio

Zacks Investment Research·6/30/2021·↑ positive

Surging Earnings Estimates Signal Upside for Harvard Bioscience (HBIO) Stock

Zacks Investment Research·6/3/2021·↑ positive

Harvard Bioscience, Inc. (HBIO) CEO James Green on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·5/9/2021·↓ negative

Harvard Bioscience Announces First Quarter 2021 Financial Results

GlobeNewsWire·5/6/2021·↑ positive

Harvard Bioscience Schedules First Quarter 2021 Earnings Conference Call for May 6, 2021 at 8:00 AM ET

GlobeNewsWire·4/19/2021·↑ positive

Harvard Bioscience, Inc. (HBIO) CEO Jim Green on Q4 2020 Results - Earnings Call Transcript

Seeking Alpha·3/10/2021·↓ negative

Harvard Bioscience Schedules Fourth Quarter 2020 Earnings Conference Call for March 10, 2021 at 8:00 AM ET

GlobeNewsWire·2/18/2021·↓ negative

Harvard Bioscience Announces New Credit Facility

GlobeNewsWire·12/22/2020·↑ positive